Quick Answer
Garlic Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines.
Key Takeaways
- 01The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines. [Deshmukh S (2025)]
- 02Result A total of 44 studies was included in the systematic review, and ten RCTs involving 524 participants were included in the meta-analysis. [Deshmukh S (2025)]
- 03Conclusion This systematic review shows that although Ayurvedic interventions do not achieve significant BP reductions versus conventional treatments, they may provide clinical benefits with good safety. [Deshmukh S (2025)]
- 04Background Essential hypertension (EH) is a major contributor to cardiovascular morbidity and mortality that has become a public health challenge owing to poor control and adherence. [Deshmukh S (2025)]
The current Migaku evidence database contains 2 reusable source documents for Garlic Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines. [Deshmukh S (2025); evidence level 1]
- Result A total of 44 studies was included in the systematic review, and ten RCTs involving 524 participants were included in the meta-analysis. [Deshmukh S (2025); evidence level 1]
- Conclusion This systematic review shows that although Ayurvedic interventions do not achieve significant BP reductions versus conventional treatments, they may provide clinical benefits with good safety. [Deshmukh S (2025); evidence level 1]
- Background Essential hypertension (EH) is a major contributor to cardiovascular morbidity and mortality that has become a public health challenge owing to poor control and adherence. [Deshmukh S (2025); evidence level 1]
- These changes likely contribute to cognitive decline, sensorimotor impairments and increased vulnerability to neurodegenerative disorders (). [Mony Tamanna (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources